Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.8500 (-4.78%) ($11.8200 - $11.8500) on Mon. Nov. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 34 | Latest Price | $11.8500(-4.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(27%) XLK(27%) URA(26%) VT(25%) BLOK(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.47% in a week (0% probabilities). SMH(-18%) VIXM(-11%) UUP(-6%) ARKG(-4%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.98(-83.29%) | Resistance Level | $13.27 | 5 Day Moving Average | $12.05(-1.66%) | 10 Day Moving Average | $12.83(-7.64%) | 20 Day Moving Average | $13.27(-10.7%) | To recent high | -20% | To recent low | 0% | Market Cap | $2.091b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |